COMPANY OVERVIEW

Cerevance is a new pharmaceutical company focused on central nervous system diseases. Their strengths include a powerful technology platform, a pipeline of novel discovery-stage and clinical-stage compounds and a proven team.

---

LOCATION

Boston, MA, USA

Milton, Cambridge, UK

---

THERAPEUTIC AREAS

Neurological DIsorders

---

WEBSITE

https://www.cerevance.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jul 10, 2023

Cerevance Announces Presentation at the Alzheimer’s Association International Conference

Jul 10, 2023

Cerevance Announces Presentation at the Alzheimer’s Association International Conference

Jun 28, 2023

Cerevance Announces Presentation at the XVI European Meeting on Glial Cells in Health and Disease

Jun 26, 2023

Cerevance Announces Presentation at the Gordon Research Conference: Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases

May 16, 2023

Cerevance Announces Oral Presentation of Phase 1 Data on CVN766 at American Society of Clinical Psychopharmacology (ASCP)

For More Press Releases

---